Seres Therapeutics, Inc. (MCRB) Social Stream



Seres Therapeutics, Inc. (MCRB): $3.83

0.20 (+5.51%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MCRB to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Seres Therapeutics Inc (MCRB) Price Targets From Analysts

Use the tables below to see what analysts covering Seres Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-16 8 $32 $16 $22.833 $7.19 217.57%
2022-03-01 7 $32 $16 $22.833 $7.19 217.57%
2022-03-07 7 $32 $13 $21.333 $7.19 196.7%

The Trend in the Analyst Price Target


MCRB's average price target has moved down $14.53 over the prior 45 weeks.

MCRB reports an average of 158.32% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-03 5 47 24 37.570 20.45 83.72%
2021-07-03 5 46 24 36.570 21.17 72.74%
2021-07-10 5 46 24 36.570 21.30 71.69%
2021-08-28 9 32 16 23.000 6.25 268%
2021-11-11 8 32 16 22.833 7.58 201.23%

MCRB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations


MCRB's average broker recommendation rating improved by 0.25 over the prior 18 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MCRB as an investment opportunity.

  • MCRB has a greater upside potential (average analyst target price relative to current price) than 266.11% of all US stocks.
  • In the context of all US stocks, Seres Therapeutics Inc's variance in analysts' estimates is lower than -154.1% of them.
  • MCRB has a higher average analyst price target than 71.78% of stocks in the mid market cap category.
  • In terms of how Seres Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 187.51% of that group.

In the Pharmaceutical Products industry, LYEL, LMDX, and LGND are the three stocks most similar to Seres Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is MCRB a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4189 seconds.